Fair point if someone’s spent the last decade ra

Fair point if someone’s spent the last decade racking up DWIs, maybe steering the National Highway Traffic Safety Administration isn’t their calling.

Just like someone who doesn’t understand monoclonal pharmacokinetics probably shouldn’t be steering FDA policy. But here we are.

Now, back to the science, the reason Leronlimab (LL) isn’t taken as a pill is because it’s a large monoclonal antibody. Try to swallow that and your stomach acid will shred it faster than the FDA shreds whistleblower emails. LL must be injected!!! subcutaneous or intravenous because only those routes protect its structure and allow proper absorption into the bloodstream.

As for storage? LL is typically stored refrigerated (2°C to 8°C), not frozen, and protected from light. Think of it like truth in government lol stable under the right conditions, but it degrades fast when exposed to heat, corruption, or political tampering.

Now, regarding the New York Times piece if Robert F. Kennedy Jr. really is dismantling the FDA, that doesn’t just shift the regulatory weather it rewrites the climate. If you remove entrenched bureaucrats, you might actually unearth the data that was buried six feet under ‘standard protocol.’ But here’s the catch deregulation alone doesn’t help LL. It still needs resubmission, reanalysis, and honest reviewers who don’t moonlight at Amarex or ghostwrite for BP.

So how does this affect LL? Depends who replaces the foxes. But if we keep our eye on the data, the chain of custody, and that cold storage unit our number one asset stays intact!!!

safety, transparency, and the will to keep jabbing when others fold.

Plainly? Yes we’re fine…..